Françoise Borsa-Lebas
Impact in
- Virology top 10%
- HIV Research and Treatment
- Pharmacology top 10%
- Antibiotics Pharmacokinetics and Efficacy
Papers in
-
- HIV/AIDS drug development and treatment 8
- HIV/AIDS Research and Interventions 1
-
- Antibiotics Pharmacokinetics and Efficacy 6
- Pharmacogenetics and Drug Metabolism 1
- Co-authors
- G. Humbert (11 shared papers)François Caron (5 shared papers)Véronique Lemee (2 shared papers)Isabelle Étienne (5 shared papers)J P Fillastre (2 shared papers)Gilles Gargala (1 shared paper)Jean-Jacques Ballet (1 shared paper)Loïc Favennec (1 shared paper)
- Journals
- Clinical Infectious Diseases (4 papers)Journal of Antimicrobial Chemotherapy (4 papers)Antiviral Therapy (1 paper)Liver International (1 paper)Journal of Clinical Virology (1 paper)
- Partner nations
- France
In The Last Decade
Françoise Borsa-Lebas
26 papers receiving 444 citations
Peers
Comparison fields: 5 of 39
- Virology 50
- Pharmacology 86
- Parasitology 49
- Infectious Diseases 119
- Pharmacology 10
Countries citing papers authored by Françoise Borsa-Lebas
This map shows the geographic impact of Françoise Borsa-Lebas's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Françoise Borsa-Lebas with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Françoise Borsa-Lebas more than expected).
Fields of papers citing papers by Françoise Borsa-Lebas
This network shows the impact of papers produced by Françoise Borsa-Lebas. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Françoise Borsa-Lebas. The network helps show where Françoise Borsa-Lebas may publish in the future.
Co-authors
The 25 scholars most cited alongside Françoise Borsa-Lebas, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 28 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 1992 | 87 | |
| 2 | 2001 | 84 | |
| 3 | 2005 | 65 | |
| 4 | 2013 | 53 | |
| 5 | 1990 | 39 | |
| 6 | 1995 | 23 | |
| 7 | 1995 | 22 | |
| 8 | 2012 | 22 | |
| 9 | 2017 | 19 | |
| 10 | 2015 | 15 | |
| 11 | 1991 | 12 | |
| 12 | 1996 | 10 | |
| 13 | 2005 | 7 | |
| 14 | 2012 | 6 | |
| 15 | 2014 | 6 | |
| 16 | 2011 | 5 | |
| 17 | 2006 | 4 | |
| 18 | Effects of ketoprofen (NSAID) on the pharmacokinetics of pefloxacin and ofloxacin in healthy volunteers. | 1992 | 3 |
| 19 | 1993 | 3 | |
| 20 | 2014 | 3 |
About Françoise Borsa-Lebas
Françoise Borsa-Lebas is a scholar working on Infectious Diseases, Pharmacology, Virology, Parasitology and Epidemiology, having authored 28 papers that have together received 494 indexed citations. Recurring topics across this work include HIV/AIDS drug development and treatment (8 papers), Antibiotics Pharmacokinetics and Efficacy (6 papers), HIV Research and Treatment (3 papers), Vector-borne infectious diseases (2 papers), Hepatitis B Virus Studies (2 papers), Urinary Tract Infections Management (2 papers), Pharmacogenetics and Drug Metabolism (1 paper) and HIV/AIDS Research and Interventions (1 paper). The work is most often cited by research in Virology (50 citations), Pharmacology (86 citations), Parasitology (49 citations), Infectious Diseases (119 citations) and Pharmacology (10 citations). Françoise Borsa-Lebas has collaborated with scholars based in France. Frequent co-authors include G. Humbert, François Caron, Véronique Lemee, Isabelle Étienne, J P Fillastre, Gilles Gargala, Jean-Jacques Ballet, Loïc Favennec, Philippe Abboud and Philippe Brasseur. Their work appears in journals such as Clinical Infectious Diseases, Journal of Antimicrobial Chemotherapy, Antiviral Therapy, Liver International and Journal of Clinical Virology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.